【Diamond Biofund】March 2026 Revenue -NT$0.085 Billion (YoY +86.9%)
NQ Score
20/100
N1 Content Completeness
2
AI Summary (NQ-processed)
Diamond Biofund (6901), which invests in the biotech sector, reported a negative monthly revenue of -NT$0.085 billion for March 2026. However, this represents an +86.9% improvement year-over-year, meaning the loss was significantly reduced.
AI Analysis
Frequently Asked Questions
- Q: What was Diamond Biofund's revenue for March 2026?
- A: Diamond Biofund's revenue for March 2026 was -84,898 thousand NTD, which is equivalent to -0.085 billion NTD.
- Q: How did Diamond Biofund's revenue in March 2026 compare to the previous year?
- A: Diamond Biofund's revenue in March 2026 showed a significant year-on-year increase of +86.9%.
- Q: What is the company code for Diamond Biofund?
- A: The company code for Diamond Biofund is 6901.
- Q: In which industry is Diamond Biofund classified?
- A: Diamond Biofund is classified under the 'Other' industry sector.
- Q: What was the specific monthly revenue figure reported for March 2026 by Diamond Biofund?
- A: The specific monthly revenue figure reported for March 2026 by Diamond Biofund was -84,898 thousand NTD.